STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Roadzen’s DrivebuddyAI Awarded Patent for Real-Time Driver Drowsiness Detection — Crosses 1.8 Billion Kilometers of Real-World AI Driving Data

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
AI
Roadzen (NASDAQ: RDZN) has secured a patent in India for DrivebuddyAI's Real-Time Driver Drowsiness Detection Algorithm, which monitors 92 eye and facial cues to prevent accidents through early fatigue detection. The platform has achieved significant milestones, including 1.8 billion kilometers of real-world driving data and a 72% reduction in fleet accidents. DrivebuddyAI is uniquely positioned as the first and only platform validated under India's upcoming AIS-184 standard, which will require Driver Drowsiness and Attention Warning Systems in all new commercial vehicles by April 2026. The regulation will impact over 1 million units annually. The company has also secured a patent for Cognitive Assessment of Risk for Drivers (CARD) and received recognition at the Bosch Excellence Awards in Mobility.
Loading...
Loading translation...

Positive

  • Secured patent for Real-Time Driver Drowsiness Detection Algorithm in India with additional filings in U.S. and Europe
  • First and only platform validated under AIS-184 standard, positioning for mandatory implementation in India by April 2026
  • Achieved 72% reduction in on-road accidents across commercial deployments
  • Reached 1.8 billion kilometers of real-world driving data, up 80% in six months
  • Secured additional patent for Cognitive Assessment of Risk for Drivers (CARD)

Negative

  • None.

News Market Reaction 1 Alert

-3.48% News Effect

On the day this news was published, RDZN declined 3.48%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

New Patent Positions DrivebuddyAI to Lead India’s Upcoming Road Safety Mandates, Achieves 72% Accident Reduction Across Fleets

NEW YORK, June 03, 2025 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) (“Roadzen” or the “Company”), a global leader in AI at the intersection of insurance and mobility, today announced that its DrivebuddyAI platform has been granted a patent in India for its Real-Time Driver Drowsiness Detection Algorithm.

DrivebuddyAI’s patented system leverages AI and computer vision to monitor over 92 real-time eye and facial cues, enabling early detection of driver fatigue and triggering instant alerts—helping prevent accidents before they occur. The newly granted patent strengthens Roadzen’s expanding global IP portfolio, with additional filings underway in the U.S. and Europe.

According to the U.S. National Highway Traffic Safety Administration (NHTSA), crashes involving at least one distracted driver accounted for 29% of all motor vehicle crashes and costs. This underscores the urgent need for real-time safety technologies like DrivebuddyAI, which directly target distraction and fatigue—the two leading contributors to road incidents globally.

This breakthrough capability is also core to compliance with India’s upcoming draft road safety regulation for commercial vehicles, that is expected to be adopted by April 1, 2026. The regulation will require Driver Drowsiness and Attention Warning Systems (DDAWS) or AIS 184 in all new commercial vehicles produced — impacting over 1 million units annually. DrivebuddyAI remains the first and only platform validated under the AIS-184 standard by the Automotive Research Association of India (ARAI), positioning Roadzen as the frontrunner in this transformational regulatory and market opportunity.

DrivebuddyAI Recent Milestones

  • Data Scale: Surpassed 1.8 billion kilometers of real-world driving—up 80% in less than six months since reaching the 1-billion-kilometer milestone.
  • Fleet Impact: Delivered a 72% reduction in on-road accidents across commercial deployments.
  • Regulatory Readiness: Fully compliant and deployment-ready ahead of India’s new commercial vehicle safety regulation.
  • CARD Patent: Secured a patent for the Cognitive Assessment of Risk for Drivers (CARD), enabling AI-based driver risk profiling.
  • Industry Recognition: Honored at the Bosch Excellence Awards in Mobility (BEAM) during the MPS Summit 2025, with DrivebuddyAI recognized as a standout partner furthering the vision of #MobilityWithoutSideEffects.

“DrivebuddyAI is fast becoming the standard for safety and compliance in fleet operations,” said Rohan Malhotra, Founder and CEO of Roadzen. “With India’s new commercial safety regulation, our first-mover advantage, patented AI, and real-world performance place us in a category of one. Fleet operators are not just adopting DrivebuddyAI for compliance—they’re seeing tangible ROI through reduced accidents, increased uptime, and lower insurance costs.”

About Roadzen Inc.
Roadzen Inc. (Nasdaq: RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients, from the world’s leading insurers, carmakers, and fleets to dealerships and auto insurance agents, use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition as a top AI innovator by publications such as Forbes, Fortune, and Financial Express. Roadzen’s mission is to continue advancing AI research at the intersection of mobility and insurance, ushering in a world where accidents are prevented, premiums are fair, and claims are processed within minutes, not weeks. Headquartered in Burlingame, California, the Company has 320 employees across its global offices in the U.S., U.K. and India. To learn more, please visit www.roadzen.ai.

Cautionary Statement Regarding Forward Looking Statements
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the annual report on Form 10-K we filed with the SEC on July 1, 2024. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:
Investor Contacts: IR@roadzen.ai
Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai


FAQ

What is the significance of Roadzen's DrivebuddyAI patent for driver drowsiness detection?

The patent strengthens Roadzen's position in India's upcoming road safety mandates, as DrivebuddyAI is the first platform validated under AIS-184 standard, which will be mandatory for all new commercial vehicles by April 2026.

How effective is DrivebuddyAI in reducing accidents for RDZN?

DrivebuddyAI has demonstrated a 72% reduction in on-road accidents across commercial fleet deployments.

What is the market opportunity for RDZN with India's new commercial vehicle safety regulation?

The regulation will impact over 1 million new commercial vehicles annually, requiring Driver Drowsiness and Attention Warning Systems (DDAWS) by April 2026, with DrivebuddyAI being the only validated platform.

How much real-world driving data has Roadzen's DrivebuddyAI collected?

DrivebuddyAI has collected over 1.8 billion kilometers of real-world driving data, showing an 80% increase in less than six months.

What technology does DrivebuddyAI use to detect driver drowsiness?

DrivebuddyAI uses AI and computer vision to monitor over 92 real-time eye and facial cues to detect driver fatigue and trigger instant alerts.
Roadzen Inc

NASDAQ:RDZN

RDZN Rankings

RDZN Latest News

RDZN Latest SEC Filings

RDZN Stock Data

133.05M
41.74M
49.25%
15.74%
0.55%
Software - Application
Insurance Agents, Brokers & Service
Link
United States
BURLINGAME